Grand challenges in major tropical diseases: Part II

COPYRIGHT © 2023 Menezes, Ferreira, Rosier, Villalva-Serra, Campos, Passos, Argolo, Santana, Garcia, Pustilnik, Silva, Barreto-Duarte, Araújo-Pereira and Andrade. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. TYPE Specialty Grand Challenge PUBLISHED 29 March 2023 DOI 10.3389/fitd.2023.1180606

[1]  J. Conn,et al.  The use of drones for mosquito surveillance and control , 2022, Parasites & vectors.

[2]  W. Haefeli,et al.  Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial. , 2022, The Lancet. Infectious diseases.

[3]  T. Clasen,et al.  Effectiveness of interventions to improve drinking water, sanitation, and handwashing with soap on risk of diarrhoeal disease in children in low-income and middle-income settings: a systematic review and meta-analysis , 2022, The Lancet.

[4]  P. Lampertico,et al.  BULEVIRTIDE WITH OR WITHOUT PEGIFNα FOR PATIENTS WITH COMPENSATED CHRONIC HEPATITIS DELTA: FROM CLINICAL TRIALS TO REAL LIFE STUDIES. , 2022, Journal of hepatology.

[5]  Matthew A. Odenwald,et al.  World Journal of Gastroenterology Viral hepatitis: Past, present, and future , 2022 .

[6]  G. E. Potter,et al.  EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil , 2022, Trials.

[7]  S. McPherson,et al.  Viral hepatitis in 2021: The challenges remaining and how we should tackle them , 2022, World journal of gastroenterology.

[8]  N. Jewell,et al.  Efficacy of Wolbachia-infected mosquito deployments for the control of dengue , 2021, The New England journal of medicine.

[9]  P. Lampertico,et al.  Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease , 2021, Gut.

[10]  M. Alomari,et al.  From hepatitis A to E: A critical review of viral hepatitis , 2021, World journal of gastroenterology.

[11]  Z. Abbas,et al.  Challenges in Formulation and Implementation of Hepatitis B Elimination Programs , 2021, Cureus.

[12]  N. Ford,et al.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis , 2020, The lancet. Gastroenterology & hepatology.

[13]  M. Castro,et al.  Spatiotemporal transmission dynamics of co-circulating dengue, Zika, and chikungunya viruses in Fortaleza, Brazil: 2011–2017 , 2020, PLoS neglected tropical diseases.

[14]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[15]  O. P. Semwal,et al.  Lower dose zinc for childhood diarrhea: a randomized, multicenter trial , 2020, The New England journal of medicine.

[16]  N. Pyrsopoulos,et al.  Liver injury induced by paracetamol and challenges associated with intentional and unintentional use , 2020, World journal of hepatology.

[17]  A. Ala,et al.  Clinical performance of Determine HBsAg 2 rapid test for Hepatitis B detection , 2020, Journal of medical virology.

[18]  J. Smith-Palmer,et al.  Impact of Stigma on People Living with Chronic Hepatitis B , 2020, Patient related outcome measures.

[19]  David L. Smith,et al.  Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017 , 2020, The Lancet. Infectious diseases.

[20]  J. Jimeno,et al.  Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents. , 2019, The New England journal of medicine.

[21]  S. Witowski,et al.  A clinical review of viral hepatitis. , 2019, JAAPA : official journal of the American Academy of Physician Assistants.

[22]  Joan M. Block,et al.  A global scientific strategy to cure hepatitis B. , 2019, The lancet. Gastroenterology & hepatology.

[23]  Jose Dario Martinez,et al.  Going Viral 2019: Zika, Chikungunya, and Dengue. , 2019, Dermatologic clinics.

[24]  M. Reis,et al.  Concomitant transmission of dengue, chikungunya and Zika viruses in Brazil: Clinical and epidemiological findings from surveillance for acute febrile illness. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  H. Rashid,et al.  Update on global epidemiology of viral hepatitis and preventive strategies , 2018, World journal of clinical cases.

[26]  J. Ward,et al.  Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel , 2018, MMWR. Morbidity and mortality weekly report.

[27]  AASLD/IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C , 2018, Clinical Liver Disease.

[28]  Eyal Oren,et al.  Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet. Infectious diseases.

[29]  K. Keddy.  Old and new challenges related to global burden of diarrhoea. , 2018, The Lancet. Infectious diseases.

[30]  T. H. Nguyen,et al.  Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet. Infectious diseases.

[31]  D. Gill,et al.  Rotavirus vaccine efficacy: current status and areas for improvement , 2018, Human vaccines & immunotherapeutics.

[32]  C. Murray,et al.  On the road to universal health care in Indonesia, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet.

[33]  E. F. Oliveira-Filho,et al.  Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses. , 2018, Acta tropica.

[34]  D. Bruzzese,et al.  Universal Recommendations for the Management of Acute Diarrhea in Nonmalnourished Children , 2018, Journal of pediatric gastroenterology and nutrition.

[35]  Noele P. Nelson,et al.  Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant , 2018, MMWR. Morbidity and mortality weekly report.

[36]  B. McMahon,et al.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance , 2018, Hepatology.

[37]  S. Weaver,et al.  Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases. , 2018, Annual review of medicine.

[38]  Noele P. Nelson,et al.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices , 2018, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[39]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[40]  P. Schmid,et al.  Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial. , 2017, The lancet. Gastroenterology & hepatology.

[41]  J. Crump,et al.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  Shuying Wang,et al.  Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection , 2017, The Journal of Immunology.

[43]  C. Byington,et al.  Elimination of Perinatal Hepatitis B: Providing the First Vaccine Dose Within 24 Hours of Birth , 2017, Pediatrics.

[44]  E. Gould,et al.  Emerging arboviruses: Why today? , 2017, One health.

[45]  R. Kamel.  AASLD 2016 Recommendations for Testing, Managing, and Treating Hepatitis C , 2017 .

[46]  Nikos Vasilakis,et al.  The emergence of arthropod-borne viral diseases: A global prospective on dengue, chikungunya and zika fevers , 2016, Acta Tropica.

[47]  J. Crump,et al.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  Jessica Patterson,et al.  Dengue, Zika and Chikungunya: Emerging Arboviruses in the New World , 2016, The western journal of emergency medicine.

[49]  H. Dupont,et al.  ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults , 2016, The American Journal of Gastroenterology.

[50]  K. Schwarz,et al.  Hepatitis Vaccines , 2016, Vaccines.

[51]  I. Kantor.  [Dengue, Zika and Chikungunya]. , 2016, Medicina.

[52]  M. Harrison.  A Global Perspective , 2015, Bulletin of the history of medicine.

[53]  Laetitia Canini,et al.  Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. , 2015, The Lancet. Infectious diseases.

[54]  Amit H Agravat,et al.  HEPATITIS C VIRUS: SCREENING, DIAGNOSIS, AND INTERPRETATION OF LABORATORY ASSAYS , 2015 .

[55]  R. Chung,et al.  Screening for Hepatitis B Virus Infection: A Public Health Imperative , 2014, Annals of Internal Medicine.

[56]  Christina Bougatsos,et al.  Screening for Hepatitis B Virus Infection in Adolescents and Adults: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation , 2014, Annals of Internal Medicine.

[57]  M. Garcia-Blanco,et al.  Targeting Host Factors to Treat West Nile and Dengue Viral Infections , 2014, Viruses.

[58]  L. Alphey,et al.  Mass Production of Genetically Modified Aedes aegypti for Field Releases in Brazil , 2014, Journal of visualized experiments : JoVE.

[59]  E. Gupta,et al.  Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays , 2014, Asian journal of transfusion science.

[60]  M. Hudson,et al.  Targeted case finding for hepatitis B using dry blood spot testing in the British–Chinese and South Asian populations of the North‐East of England , 2013, Journal of viral hepatitis.

[61]  M. Salam,et al.  Acute diarrhea in adults and children: a global perspective. , 2013, Journal of clinical gastroenterology.

[62]  S. Soldan,et al.  Arboviral Encephalitides: Transmission, Emergence, and Pathogenesis , 2010, Journal of Neuroimmune Pharmacology.

[63]  R. Black,et al.  Progress and barriers for the control of diarrhoeal disease , 2010, The Lancet.

[64]  M. Chopra,et al.  Diarrhoea: why children are still dying and what can be done , 2010, The Lancet.

[65]  T. Baumert,et al.  Development of hepatitis C virus vaccines: challenges and progress , 2009, Expert review of vaccines.

[66]  J. Zuckerman.  Review: hepatitis B immune globulin for prevention of hepatitis B infection , 2007, Journal of medical virology.

[67]  Wei Liu,et al.  A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. , 2007, The Journal of infectious diseases.

[68]  Sergio L. Schmukler,et al.  Emerging Market Instability : Do Sovereign Ratings Affect Country Risk and Stock Returns ? , 1997 .

[69]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[70]  T. Fritsche,et al.  LABORATORY APPROACHES TO INFECTIOUS DIARRHEA , 2001, Gastroenterology Clinics of North America.

[71]  A. Eddleston.  Hepatitis , 1990, The Lancet.

[72]  Selma Cvijetić Avdagić,et al.  New Edition , 1952, Renaissance Quarterly.